Intravenous thrombolysis for stroke increases over time at primary stroke centers

Stroke

Volumn 43, Issue 3, 2012, Pages 875-877

  Prabhakaran, Shyam ^a   McNulty, Maggie ^a   O'Neill, Kathleen ^a   Ouyang, Bichun ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

certification; quality improvement; tissue type plasminogen activator

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ACUTE ISCHEMIC STROKE; AGED; ARTICLE; BRAIN ISCHEMIA; CERTIFICATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG UTILIZATION; FEMALE; HEALTH INSURANCE; HOSPITAL ADMISSION; HOSPITAL BED; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PRIMARY HEALTH CARE; PRIMARY STROKE CENTER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

AGED; BRAIN ISCHEMIA; CERTIFICATION; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG UTILIZATION; FEMALE; FIBRINOLYTIC AGENTS; HEALTH FACILITIES; HEALTH FACILITY SIZE; HUMANS; ILLINOIS; INJECTIONS, INTRAVENOUS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84857648211     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.640060     Document Type: Article

References (11)

1. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: A doubling of treatment rates over the course of 5 years. Stroke. 2011;42:1952-1955.
2. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924-928.
3. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711.
4. Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA. 2000;283:3102-3109.
5. Lichtman JH, Allen NB, Wang Y, Watanabe E, Jones SB, Goldstein LB. Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. Stroke. 2009;40:3574-3579.
6. Douglas VC, Tong DC, Gillum LA, Zhao S, Brass LM, Dostal J, et al. Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke? Neurology. 2005;64:422-427.
7. Lattimore SU, Chalela J, Davis L, De Graba T, Ezzeddine M, Haymore J, et al. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: The NINDS Suburban hospital stroke center experience. Stroke. 2003;34:e55-e57.
8. Demaerschalk BM, Bobrow BJ, Paulsen M, Phoenix Operation Stroke Executive Committee. Development of a metropolitan matrix of primary stroke centers: The Phoenix experience. Stroke. 2008;39:1246-1253.
9. Gladstone DJ, Rodan LH, Sahlas DJ, Lee L, Murray BJ, Ween JE, et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009;40:3841-3844.
10. Gropen TI, Gagliano PJ, Blake CA, Sacco RL, Kwiatkowski T, Richmond NJ, et al. Quality improvement in acute stroke: The New York State Stroke Center Designation Project. Neurology. 2006;67:88-93.
11. Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke. 2005;36:1512-1518.